Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Sprague

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Psychopharmacology Bulletin|October 1, 1978
Psychopharmacology of the retarded: present and futureR L Sprague
Psychopharmacology Bulletin|January 1, 1982
An analysis of institutionalized retarded residents using DIS-COR L Sprague
Annals of the New York Academy of Sciences|February 28, 1973
Minimal brain dysfunction from a behavioral viewpointR L Sprague
Science and Engineering Ethics|November 8, 2001
Mentoring and the responsible conduct of research: reflections and futureS J Bird, R L Sprague
American Journal of Mental Retardation : AJMR|May 1, 1989
Psychotropic medication of mentally retarded residents in community long-term care facilitiesJ A Buck, R L Sprague
Science (New York, N.Y.)|December 23, 1977
Methylphenidate in hyperkinetic children: differences in dose effects on learning and social behaviorR L Sprague, E K Sleator
Psychiatric Services (Washington, D.C.)|November 1, 1996
Psychology update. Integrating research in stereotypic behaviorR L Sprague, G R VandenBos
The Annals of Pharmacotherapy|February 1, 1994
How well do physicians, pharmacists, and psychologists assess tardive dyskinesia movements?J E Kalachnik, R L Sprague
Psychopharmacology Bulletin|January 1, 1984
Preventing tardive dyskinesia and preventing tardive dyskinesia litigationC T Gualtieri, R L Sprague
Psychopharmacology Bulletin|January 1, 1991
Reliability, validity, and a total score cutoff for the dyskinesia identification system: condensed user scale (DISCUS) with mentally ill and mentally retarded populationsR L Sprague, J E Kalachnik
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Psychopharmacology Bulletin|October 1, 1978
Psychopharmacology of the retarded: present and futureR L Sprague
Psychopharmacology Bulletin|January 1, 1982
An analysis of institutionalized retarded residents using DIS-COR L Sprague
Annals of the New York Academy of Sciences|February 28, 1973
Minimal brain dysfunction from a behavioral viewpointR L Sprague
Science and Engineering Ethics|November 8, 2001
Mentoring and the responsible conduct of research: reflections and futureS J Bird, R L Sprague
American Journal of Mental Retardation : AJMR|May 1, 1989
Psychotropic medication of mentally retarded residents in community long-term care facilitiesJ A Buck, R L Sprague
Science (New York, N.Y.)|December 23, 1977
Methylphenidate in hyperkinetic children: differences in dose effects on learning and social behaviorR L Sprague, E K Sleator
Psychiatric Services (Washington, D.C.)|November 1, 1996
Psychology update. Integrating research in stereotypic behaviorR L Sprague, G R VandenBos
The Annals of Pharmacotherapy|February 1, 1994
How well do physicians, pharmacists, and psychologists assess tardive dyskinesia movements?J E Kalachnik, R L Sprague
Psychopharmacology Bulletin|January 1, 1984
Preventing tardive dyskinesia and preventing tardive dyskinesia litigationC T Gualtieri, R L Sprague
Psychopharmacology Bulletin|January 1, 1991
Reliability, validity, and a total score cutoff for the dyskinesia identification system: condensed user scale (DISCUS) with mentally ill and mentally retarded populationsR L Sprague, J E Kalachnik
Pageof 6